维普中文期刊产品整合服务
201篇 您的检索式:作者名="Gimm"
    题名 作者 年代 出处 被引量
1Sporadic versus hereditary gastrinomas of the duodenum and pancreas: Distinct clinico-pathological and epidemiological features显示文摘Gastrinomas are defined as gastrin secreting tumors that are associated with Zollinger-Ellison syndrome (ZES). ZES is characterized by elevated fasting gastrin serum levels, positive secretin stimulation test and clinical symptoms such as recurrent peptic ulcer disease, gastroesophageal re?ux disease and occasional diarrhea. Genetically, nonhereditary (sporadic) gastrinomas are distinguished from hereditary gastrinomas, which are associated with multiple endocrine neoplasia type 1 (MEN1) syndrome. In general, duodenal gastrinomas are small and solitary if they are sporadic and multiple as well as hereditary. The sporadic gastrinomas occur in the duodenum or in the pancreas while the hereditary gastrinomas almost all occur in the duodenum. Our series of 77 sporadic duodenal neuroendocrine tumors (NETs) includes 18 patients (23.4%) with gastrinomas and ZES. Of 535 sporadic NETs in the pancreas collected from the NET archives of the departments of pathology in Zürich, Switzerland, and Kiel, Germany, 24 patients (4.5%) suffered from sporadic pancreatic gastrinomas and ZES. These NETs have to be distinguished fromtumors with immunohistochemical positivity for gastrin but without evidence of ZES. An additional 19 patients suffered from MEN1 and ZES. These patients showed exclusively duodenal gastrinomas, but not pancreatic gastrinomas. The prognosis of sporadic and MEN1- associated duodenal gastrinomas is better than that of pancreatic gastrinomas, since they progress slowly to liver metastasis. In summary, sporadic and MEN1- associated gastrinomas in the duodenum and pancreas show different clinico-pathological and genetic features. The incidence of sporadic duodenal gastrin-producing tumors is increasing, possibly due to optimized diagnostic procedures. In contrast, pancreatic MEN1- associated gastrinomas seem to be extremely rare. A considerable subset of tumors with immunohistochemical expression of gastrin but without evidence of ZES should be designated as functionally inactive NETs expressing gastrin, but not as gastrinomas.Martin Anlauf Nele Garbrecht Tobias Henopp Anja Schmitt Regina Schlenger Andreas Raffel Markus Krausch Oliver Gimm Claus F Eisenberger Wolfram T Knoefel Henning Dralle Paul Komminoth Philipp U Heitz Aurel Perren Günter Klppel 2006World Journal of Gastroenterology2006,12,34:7
2Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer显示文摘Scheumann GF Gimm K Wegener G 1994World J Surg1994,18,:1
3Critical size of residual adrenal tissue and recovery from impaired earty postoperative adrenocortical function after subtotal bilateral adrenalectomy 显示文摘Brauckhoff M Gimm O Thanh P N 2003Surgery2003,134,6:1
4An update of thyroid surgery显示文摘Gimm O Brauekhoff M Thanh PN 2002Eur Nuel Med2002,29,2:1
5Somatic and occult germline mutations in SDHD, a mitochondrial complex I! gene, in nonfamilial pheochromocytoma 显示文摘GIMM O ARMANIOS M DZIEMA H 2000Cancer Res2000,60,24:1
6Epigenetic PTEN silencing in malignant melanomas without PTEN mutation显示文摘Zhou XP Gimm O Hampel H 2000Am J Pathol2000,157,:1
7Mutation analysisreveals novel sequence variants in NTRK1 in sporadic humanmedullary thyroid carcinoma 显示文摘Gimm 0 Greco A Hoang-Vu C 1999J Clin Endocrinol Metab1999,84,:1
8Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors显示文摘Gimm O Perren A Weng LP 2000Am J Pathol2000,156,:1
9Functional characterization of spectrin-actin-binding domains in 4,1 family of proteins 显示文摘Gimm JA An XL Nunomura W 2002Biochemistry2002,41,23:1
10CpG islandmethylation of tumor-related promoters occurs preferentially in undif-ferentiated carcinoma显示文摘Schagdarsurengin U Gimm O Hoang-Vu C 2006Thyroid2006,16,7:1
11Repeat adrenocortical-sparing adrenalectomy for recurrent pheochromocytoma显示文摘Brauckhoff M Gimm O Brauckhoff K 2004Surg Today2004,34,:1
12Frequent epigenetic silencing of the cpG island promoter of RASSFIA in thyroid carcinoma显示文摘Undraga Schagdarsuregin Oliver Gimm Cuong Hoang-Vu 2002Cancer Res2002,62,:1
13An update of thyroid surgery显示文摘Gimm O Brauckhoff M Thanh PN 0,,2:1
14Somatic and occult germ-line mutations in SDHD,a mitochondrial complex II gene,in nonfamilial pheochromocytoma显示文摘 Armanios M Dziema H 2000Cancer Res2000,1560,24:1
15Frequent epigenetic silencing of the CPG island promoter of RASSF1A in thyroid carcinoma显示文摘Schagdarsurengin U Gimm O Hoang-Vu C 2002Cancer Res2002,62,13:1
16Ectopic intrathyroidal thymus diagnosed as a solid thyroid lesion:case report and review of the literature显示文摘Gimm O Krause U Wessel H 0,,08:1
17Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma 显示文摘SCHAGDARSURENGIN U GIMM O HOANG-VU C 2002Cancer Res2002,62,:1
18Intraoperative quick insulin assay to confirm complete resection of insulinomas guided by se- lective arterial calcium injection (SACI) 显示文摘Gimm V K6nig E Thanh PN 2007Langenbecks Arch Surg2007,392,6:1
19CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma显示文摘SCHAGDARSURENGIN U GIMM O DRALLE H 2006Thyroid2006,16,7:1
20CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma显示文摘SCHAGDARSURENG1N U GIMM O DRALLE H 2006Thyroid2006,16,7:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费